Figure 1From: Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patientsMRI images before (A, B) and after (C, D) bevacizumab treatment in Patient No. 5. Patient No. 5 (Table1) received two cycles of bevacizumab (7.5 mg/kg, two-week intervals) for brain metastatic tumor from non-small cell lung carcinoma cancer. The patient also received cyberknife treatment system based FSRT with 31.5 Gy in three fractions seven months prior to treatment.Back to article page